Blue Horseshoe Stocks: PBR, INO, RAD Reviews & More

Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

PBR has continued to perform this week after we caught it coming off its 52-week lows two Thursday’s ago. At that time one of our main areas of interest was the 05/01 $6.50 Calls, which we subsequently observed trading at a low of .22. This week they’ve attained a high of .71, marking off a tidy 222% move.

The last time we touched upon PBR options on Monday morning, it was in the process of pushing even higher, so we suggested the possibility of rolling up our strike price to  both the Weekly and May 1st $7 Calls, and that idea turned out to be a good one as well.

We’ve witnessed a trading range on the Weekly $7′s from .06 -.25, a whopping 316%, while the May 1st $7′s enjoyed an 87% run from .30 to .56.


Inovio Pharmaceuticals, Inc. INO 

INO stands among those stocks that we have covered the most over the years. An INO tag search of our archives yields no less than 30 results. We re-flagged it in yesterday’s premarket report and the timing was quite fortuitous.

Yesterday morning the company had announced it had been selected as the leader of a $45M DARPA program to develop practical treatments for the Ebola virus. It fueled a continued rise off of recent lows, and this morning’s news could contribute to that as well.  >> READ PR

INO heralded positive results from one of its studies, a DNA-based immunotherapy for the treatment of head and neck cancer. According to the CFO, the “initial data set from Inovio’s first cancer study provides encouraging evidence that we are on an important path to better optimized immunotherapy products.” >> READ PR

We’ll continue to keep watch over INO in the wake of these major developments.


Molycorp, Inc. MCP

MCP started showing up on our scanner back on March 23rd and 24th, when it was trading around .38. It retraced back to its 52-week low of .32 on the 27th.

After reappearing on our extended watchlist yesterday, it has traded as high as .62 in the premarket today; from a low of .484 that’s a 28% move up.

At .62, MCP had shown us a 94% overall move from its ultimate low set just the week before last. With gold and other precious metal prices on the rise again, we’ll continue to track MCP for more potential gain opportunities.


Rite-Aid Corp. RAD

We also wanted to make a quick mention of RAD. We tagged the stock for tracking back on December 4th and on that day we observed the lowest price the stock has traded at since then (5.48).

Since that time the stock has crept (and sometimes leaped) its way up the chart; it broke its 50DMA in early March, and managed break the $9-mark last Thursday, and then again yesterday. At Thursday’s high of 9.07, we had witnessed a total gain of 65%

Wall Street analysts are giving RAD high marks, and the stock is also receiving a 96% Overall “Buy” Rating at BARCHART.COM so we’ll certainly want to keep a close watch on RAD moving forward in the event that it sustains the bullish patterns it has been exhibiting over the past several months.


Extended Watchlist:
EXEL, OPXA, WPCS, MPET, MSTX, SLTD

Blue Horseshoe Stocks: LPCN Recap, LPDX & More

Lipocine, Inc. LPCN

LPCN served up an opportunity at some decent intraday gains after appearing on yesterday morning’s extended watchlist.

The stock played out a classic dip and rip scenario, falling to a morning low of 6.89 before surging back in the afternoon to a subsequent high of 8.42. That offered traders a chance at intraday gains of up to 22% on plenty of liquidity- the stock would trade 23.5X its 30-day average volume.

The productive session came on the heels of the company announcing favorable results from Phase-3 clinical testing of “LPCN 1021″, its oral treatment for low testosterone >>> VIEW PR


LipoScience, Inc. LPDX

LPDX is gapping up heavily in the premarket, and the interesting story behind it is one that we’re definitely going to want to give our close attention. Early this morning, the company announced that it was the subject of a buyout that would be executed at a share price of $5.25. Barely an hour later, another PR hit the LPDX newswire, concerning an investigation of the managerial board’s handling of the deal, and whether or not they have secured the best possible buyout price.

According to the investigative firm leading the case, “The $5.25 per share acquisition price is far less than where the stock has recently traded. In fact, on January 25, 2013, LipoScience stock opened for trading at $9.75 the day the Company sold 5.0 million shares of stock in its initial public stock offering.” >>> VIEW PR

The playing out of this scenario is going to be an interesting story moving forward, which is why we wanted to flag LPDX this morning, and fill everyone in on this morning’s happenings. The possibility that the investigation could lead to a potential restructuring of the buyout is enough to have us keep our ears to the tracks on this one for the foreseeable future.


Magnum Hunter Resources Corp. MHR

MHR is another morning gapper that we’re putting on our radars. This morning Magnum announced impressive throughput volumes on its “Eureka Hunter” gas gathering pipeline. According to the CEO, “increased capacity has resulted in a record day of approximately 316,500 MMBtu of natural gas”. >>> VIEW PR


Options Trading Idea: PBR Calls 

We’re interested in the PBR October 31st $15.50 Calls  last traded at 1.88. If we can see PBR make its way back to recent $20+ highs within a month, it could put us in position to see returns of up to 150-200% on those contracts.


Extended Watchlist:
 RNN, MNKD, CNET, VHC, MPET

BFGC, LWSP & Extended Watchlist

Bullfrog Gold Corp. BFGC

BFGC is new to our reports this morning as a stock that caught our attention yesterday on one of our routine scans. The stock recently broke through its 200DMA, and chart conditions are looking ripe, so we wanted to make certain that we passed the ticker along to you.

Yesterday the company announced that it would start its third drill program at its Newsboy Gold Project located 45 miles NW of Phoenix, Arizona. The 30-hole drill program is scheduled for completion by early April 2013.

___

Legacy Wine & Spirits International Ltd. LWSP

LWSP was a big winner for us yesterday, coming off of our extended watchlist with a really good session; the stock opened at .006, and closed at the HOD of .0099 on over 3.5x its 3mo. average volume.

A single-day gain of 65% from LWSP has definitely earned the stock a top spot on our watchlists for the remainder of the week. Closing at the HOD is often a bullish sign, so we would like to see the stock finish out the week posting higher highs and higher lows for it to continue its uptrend.

___

Added Note:
AAPL and SPY are both gapping up and we will be looking at the calls today. We expect a pullback from some profit taking out of the gate, followed by a rebound.

____

Extended Watchlist:
CCRY, INVA, KSWS, PSDV, MPET, RENU

PPHM, GLRP, WAFR & Extended Watchlist

Peregrine Pharmaceuticals, Inc. PPHM

After the big sell-off and gap-down early this week, PPHM has provided us with some nice intraday swings, showing high volatility. Over the course of the week, it has traded in a range between .80 and 1.94, for a difference of over 140% There have also been several chances in the meantime to rake in even more percentage gains. It is for this reason, we feel we must continue to talk about this stock; It has presented us with one opportunity after another.

____

Glen Rose Petroleum Corp. GLRP

As much as everyone loves the 50-100% or better gains, 15-20% gains are nothing to sneeze at, and certainly do add up. So far, GLRP looks like it is going to be a nice play, with a range yesterday of .07-.087 (+24%). It closed at the .087 high-of-day, which is often a good sign of further gains to come. A good first day of coverage for us, and we are eager to see how this one plays out over a longer period.

____

COREwafer Industries, Inc. WAFR

WAFR appeared in last Friday’s Extended Watchlist, and after trading as low as .035 on Monday, reached .0595 (yesterday’s closing price). It maintained higher lows and higher highs since the beginning of the week. We had noticed this play coming off of its bottom last week, and after a 70% gain, are still under the impression that the uptrend could continue.

____
Extended Watchlist:

FRCN, EGCT, OCLS, GOK, MPET, ROYL, ACHN,